Clinical Trial Services

May 26, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
EMA confirms its recommendation to suspend medicines approved based on GVK Biosciences studies.
Apr 15, 2015
By Pharmaceutical Technology Editors
Pfizer announces that its Phase III trial for Ibrance met its primary endpoint and was ended early due to efficacy based on an assessment by an independent Data Monitoring Committee.
Feb 13, 2015
BioPharm International
The new center represents AmerisourceBergen’s first facility erected specifically for clinical trial and commercial third-party logistics activities.
Jan 23, 2015
By Pharmaceutical Technology Editors
EMA Recommends Suspension of 700 Drugs Tested at GVK Site GVK Biosciences argues that EMA’s recommended suspension of 700 drugs is disproportional to reported infractions.
Aug 01, 2014
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.
Feb 01, 2014
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The relatively low success rates for bio/pharmaceutical compounds in clinical development have prompted many organizations to explore ways of reducing risk in clinical development.
Feb 01, 2014
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Geographic location, customs and drug-development regulations knowledge, and transportation infrastructure were factors in Catalent Pharma Solutions' selection of Shanghai for its clinical-trials supply facility.
Nov 06, 2013
By Pharmaceutical Technology Editors
ISPE’s survey is industry’s first large-scale effort to collect data on patient experiences with clinical trial materials.
May 02, 2012
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Clinical research organizations see reform in clinical-trial process, including the establishment of chief innovation officer at FDA.
Oct 02, 2011
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The authors examine risk management relating to the quality issues of clinical-trial materials and discuss areas that would benefit from additional consideration and harmonization.
native1_300x100
lorem ipsum